about
Pathways towards and away from Alzheimer's diseaseRosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neuronsGlutamate and neurotrophic factors in neuronal plasticity and diseaseNanotechnology in neurology: Genesis, current status, and future prospectsAstaxanthin as a Potential Neuroprotective Agent for Neurological DiseasesOxidized cholesterol as the driving force behind the development of Alzheimer's diseaseBehavioral stress fails to accelerate the onset and progression of plaque pathology in the brain of a mouse model of Alzheimer's diseasePoor oral health as a chronic, potentially modifiable dementia risk factor: review of the literatureBiology of Parkinson's disease: pathogenesis and pathophysiology of a multisystem neurodegenerative disorderStructural Neuroimaging Genetics Interactions in Alzheimer's DiseaseGenome-wide survey of large rare copy number variants in Alzheimer's disease among Caribbean hispanicsBiomarkers: Potential Uses and LimitationsGenomewide association study for onset age in Parkinson disease.Spontaneously Hypertensive Rats (SHR) Are Resistant to a Reserpine-Induced Progressive Model of Parkinson's Disease: Differences in Motor Behavior, Tyrosine Hydroxylase and α-Synuclein ExpressionGenomewide linkage study of modifiers of LRRK2-related Parkinson's disease.The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study.Genome scan in familial late-onset Alzheimer's disease: a locus on chromosome 6 contributes to age-at-onsetAlzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents.SMF-1, SMF-2 and SMF-3 DMT1 orthologues regulate and are regulated differentially by manganese levels in C. elegansFamily-based genome scan for age at onset of late-onset Alzheimer's disease in whole exome sequencing dataPost- versus presynaptic plasticity in L-DOPA-induced dyskinesia.Risk of Parkinson's disease after tamoxifen treatment.Mood, memory and movement: an age-related neurodegenerative complex?Genomic convergence and network analysis approach to identify candidate genes in Alzheimer's disease.Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.Genome-wide association of familial late-onset Alzheimer's disease replicates BIN1 and CLU and nominates CUGBP2 in interaction with APOEGenetic aspects of behavioral neurotoxicologyNovel nanomaterials for clinical neuroscience.Antioxidant therapy in Alzheimer's disease: theory and practice.Cellular and molecular mechanisms of hippocampal activation by acute stress are age-dependent.The mitochondrial chaperone protein TRAP1 mitigates α-Synuclein toxicityPerimenopausal risk factors and future health.Disrupted small-world brain networks in moderate Alzheimer's disease: a resting-state FMRI studyThe importance of cognitive aging for understanding dementia.Genome-wide association studies in Alzheimer's disease: a reviewGenetics of Alzheimer diseaseGenetics of Alzheimer's disease: a centennial reviewLong-lasting and transgenerational effects of an environmental enrichment on memory formationDorsal and ventral hippocampus modulate autonomic responses but not behavioral consequences associated to acute restraint stress in rats.Alterations of the sphingolipid pathway in Alzheimer's disease: new biomarkers and treatment targets?
P2860
Q24596270-8916057E-8567-47A4-ACD2-95FB3BCDB235Q24652687-D8327F4C-2658-4CD4-88AA-8C9E6F0476C6Q24653626-952B45C9-0D3C-4D7A-BAEE-B42E10CA7E9BQ26771772-017B6FF9-0BDF-4B38-B0CD-B8CC0F51BE55Q26785969-E4BEFCDC-501E-4895-99DA-33F49B89D818Q27023315-3B5C378A-18A7-4537-90FB-43F4FB54DFE2Q27321391-077FA0D6-D54D-4295-AA51-6A99C0FF62A5Q28296999-13634A73-D6CA-4AC3-BF47-C25C02E90213Q28392275-86C3757D-28ED-42E1-9D78-D946F22F87D2Q28601824-9BC54C98-7A8F-4BDB-A21F-BFD0917782FEQ28732171-6A14CE55-3A34-45B6-AA77-D34C11730195Q28972459-C85E99E3-DCBB-466B-BF30-656B42AC2B2BQ29417034-6849FAA1-02DA-41C6-BBD3-B42720DCA727Q30359033-1C8CA88C-D9FE-45A1-BDAD-3CE1C53EC1E9Q30425270-7EAD8C1E-66F2-497C-90A4-B446B9545CB6Q30440660-B817768B-4717-4C38-AA84-57D907DA4F6FQ30539808-B779D2CB-B076-4712-BF50-3846F51AD6C6Q30666219-6B8D49C4-B715-45FD-B9C6-E794839A5451Q30895194-B3F8D0A1-760B-4A2F-8DF7-BA8C82E80524Q30995743-F8C19270-6413-4D3B-A053-165C26B4A121Q33255884-5A126271-0813-4C79-930F-C28E74CB3EAFQ33552831-EC71F526-1CA9-4B38-9B37-287400A05903Q33554878-1D0CC983-FF4F-48D7-80CF-191E35F7D487Q33637672-78F6229B-4208-499E-96FA-9BF7E18FAD4FQ33726019-95C262C4-EBF2-463D-A785-F62DCD447C98Q33838241-1B3A0BB2-68F3-481C-9687-4632B3999D1AQ33863714-7B2DCF2E-2189-4254-8CB4-F09EB004BF23Q34009532-2054286C-31B1-4968-9993-A45DEC6E6E9EQ34066474-140E59AA-003A-43E4-9779-503AC0CD4070Q34083008-B87A6FE5-EC45-47A4-BF0A-75A55C6FAB56Q34154475-832E0A96-A368-41B9-9155-1EAB9B30AC42Q34184608-70D54408-5179-47F8-8A8B-26D2AB079963Q34211926-655FD71F-F6C3-45AB-A215-C1BC1876A068Q34306400-79321BD8-D881-4363-A57A-BD90F06D7C1EQ34364850-2E03E6CB-7394-4D96-887E-A124C6B3BAF5Q34604101-593EC7EE-E107-49CE-936A-40A18E06988AQ34656812-108EB733-B223-4A4E-B1B5-D55EAE8B1C22Q34758103-48030BC8-C4F1-4AF8-91C5-6A680FE5C34FQ35023383-03A6C8CF-1D82-480E-858F-5027258E04F4Q35086073-F3181FCD-C96F-41F2-AD65-86802B95078A
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Epidemiology of neurodegeneration.
@ast
Epidemiology of neurodegeneration.
@en
type
label
Epidemiology of neurodegeneration.
@ast
Epidemiology of neurodegeneration.
@en
prefLabel
Epidemiology of neurodegeneration.
@ast
Epidemiology of neurodegeneration.
@en
P1476
Epidemiology of neurodegeneration.
@en
P304
P356
10.1146/ANNUREV.NEURO.26.043002.094919
P577
2003-01-24T00:00:00Z